A New Strategy to Treat Disease
Synlogic is harnessing synthetic biology to design smart living biotherapeutics, medicines programmed with specific genes and molecular components, to address dysregulation and other drivers of disease. Synthetic Biotic™ medicines have the potential to treat a range of conditions including rare diseases, metabolic conditions, autoimmune and inflammatory diseases and cancers.
Delivering Our Medicines for Optimal Effect
Synlogic’s Synthetic Biotic medicines are created to act locally for a systemic effect. Certain medicines like our therapy for PKU are administered orally, working through the gut to impact disease. Our cancer therapies are delivered directly into the tumor to stimulate local immune activity which subsequently triggers a systemic anti-tumor response.